VI
MRNA icon

Vestcor Inc’s Moderna MRNA Stock Holding History

Vestcor Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,565
Closed -$186K – 1205
2025
Q1 		$186K Sell
6,565
-4
-0.1% -$142 0.01% 972
2024
Q4 		$273K Buy
6,569
+855
+15% +$40.9K 0.01% 900
2024
Q3 		$382K Hold
5,714
– – 0.01% 788
2024
Q2 		$679K Hold
5,714
– – 0.02% 550
2024
Q1 		$609K Sell
5,714
-1,190
-17% -$120K 0.02% 582
2023
Q4 		$687K Sell
6,904
-75
-1% -$6.31K 0.02% 551
2023
Q3 		$721K Sell
6,979
-849
-11% -$94.7K 0.03% 509
2023
Q2 		$951K Sell
7,828
-26
-0.3% -$3.47K 0.03% 437
2023
Q1 		$1.21M Sell
7,854
-1,326
-14% -$219K 0.04% 392
2022
Q4 		$1.65M Sell
9,180
-2,288
-20% -$374K 0.06% 338
2022
Q3 		$1.36M Sell
11,468
-2
-0% -$303 0.05% 399
2022
Q2 		$1.64M Buy
11,470
+6,020
+110% +$860K 0.06% 365
2022
Q1 		$939K Sell
5,450
-10,390
-66% -$1.75M 0.03% 503
2021
Q4 		$4.02M Sell
15,840
-1,816
-10% -$531K 0.14% 160
2021
Q3 		$6.79M Buy
17,656
+3,019
+21% +$1.11M 0.25% 112
2021
Q2 		$3.44M Buy
+14,637
New +$2.62M 0.12% 209

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vestcor Inc's MRNA Position: Q2 2025 in Review

Vestcor Inc sold out of Moderna (MRNA) in Q2 2025, closing a stake of 6,565 shares — an estimated $186K sold.

Vestcor Inc first reported a position in MRNA in Q2 2021 and held it in 16 quarters. The position peaked at $6.79M in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Vestcor Inc reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Vestcor Inc sold 6,565 Moderna shares in Q2 2025, an estimated $186K.
  • Vestcor Inc first reported a position in Moderna in Q2 2021 and held it in 16 quarters.
  • Vestcor Inc's Moderna position peaked at $6.79M in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Vestcor Inc's 13F filing for Q2 2025, filed 8 Aug 2025.